New chemo cocktail aims to make inoperable stomach cancer removable
NCT ID NCT05184803
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of three chemotherapy drugs (docetaxel, oxaliplatin, and S-1) given before surgery to people with advanced stomach cancer that cannot be removed right away. The goal is to shrink the tumor enough so that surgery can remove it completely. About 63 adults with stomach cancer that has spread to nearby tissues or lymph nodes will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center, University of Ulsan College of Medicine
RECRUITINGSeoul, Seoul, 138-736, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can immunotherapy outperform chemo after stomach cancer surgery?
- Could a smartphone program supervised by AI boost recovery after stomach cancer surgery?
- A simple test could spot who will develop stomach cancer
- Can stomach cancer surgery also tame diabetes?